第一章 国际药品监管科学概述
Chapter 1 Introduction on International
Drug Regulatory Science002
第一节监管科学的起源
…………………………………………………………
2
Ⅰ. Origin of Regulatory Science
一、历史背景
……………………………………………………………………
2
1. Historical Background
二、“监管科学”的由来
…………………………………………………………
2
2. Birth of “Regulatory Science”
三、“监管科学”涵义界定
………………………………………………………
3
3. Definition of “Regulatory Science”
四、监管科学研究的科学范畴
…………………………………………………
3
4. Scientific Scope of Regulatory Science Research
第二节监管科学的发展历程
……………………………………………………
5
Ⅱ. The Evolution of Regulatory Science
一、医学发展与监管科学
………………………………………………………
5
1. Medical Development and Regulatory Science
二、新兴科技与监管科学
………………………………………………………
7
2. Emerging Technologies and Regulatory Science
第三节监管科学战略计划
……………………………………………………
12
Ⅲ. Strategic Plans for Regulatory Science
一、美国监管科学战略计划
…………………………………………………
12
1. Strategic Plan for Regulatory Science in the U.S.
二、欧盟药品监管科学战略计划
……………………………………………
13
2. Strategic Plan for Regulatory Science in the EU
三、日本药品监管科学战略计划
……………………………………………
14
3. Strategic Plan for Regulatory Science in Japan
Part One
General Introduction
上篇概论
篇
中药监管科学
第四节监管科学研究的组织架构与人才培养………………………………
15
Ⅳ. Organizational Structure and Personnel Training of Regulatory Science
Research
一、监管科学研究的组织架构
………………………………………………
15
1. Organizational Structure of Regulatory Science Research
二、监管科学的学科体系与人才培养
………………………………………
16
2. Discipline System and Personnel Training of Regulatory Science
第五节全球监管科学研究机制与全球监管科学峰会
……………………
19
Ⅴ. GCRSR and GSRS
一、全球监管科学研究机制
…………………………………………………
19
1. Global Coalition for Regulatory Science Research (GCRSR)
二、全球监管科学峰会
………………………………………………………
22
2. Global Summit of Regulatory Science (GSRS)
三、中国参与全球监管科学研究机制工作情况
……………………………
24
3. China’s Participation in GCRSR
第二章 中国药品监管科学的发展
Chapter 2 Development of Drug Regulatory
Science in China027
第一节我国药品监管的科学化进程
…………………………………………
27
Ⅰ. Scientific Progress of Drug Regulation in China
一、起步阶段
…………………………………………………………………
28
1. The Beginning Stage
二、发展阶段
…………………………………………………………………
28
2. The Development Stage
三、改革阶段
…………………………………………………………………
28
3. The Reform Stage
四、提升阶段
…………………………………………………………………
29
4. The Improvement Stage
第二节中国药品监管科学发展规律和特点…………………………………
31
Ⅱ. Rules and Characteristics of Drug Regulatory Science Development
in China
一、建立国家层面多方协同的创新支撑体系
………………………………
32
1. Establishment of National Level Innovation Supporting System with
Multiple Coordination
二、形成国际化的新指南、新标准、新方法开发模式
……………………
32
2. Formation of Internationalization on New Guidelines, New Standards and
New Methods
目 录
三、创新中药监管科学体系促进中药传承创新发展
………………………
33
3. Innovation on the Regulatory Science System on Traditional Chinese
Medicines (TCM) to Promote the Inheritance, Innovation and Development
of TCM
第三节监管科学在我国药品监管中的重要作用
…………………………
34
Ⅲ. Significance of Regulatory Science on Drug Regulation in China
一、筑牢药品监管的科学基础
………………………………………………
34
1. Consolidation on the Scientific Basis of Drug Regulation
二、提升药品监管的能力
……………………………………………………
34
2. Improvement on the Capacity of Drug Regulation
三、助力药物研发创新
………………………………………………………
35
3. Facilitation on Drug Research and Innovation
四、促进监管国际化现代化
…………………………………………………
35
4. Promotion on the Internationalization and Modernization of Drug Regulation
第三章 中药监管的科学化进程
Chapter 3 Scientific Progress of TCM
Regulation036
第一节传统经验鉴别
…………………………………………………………
36
Ⅰ. Identification Based on Traditional Experience
一、技术方法演进及应用
……………………………………………………
36
1. Evolution and Application of Technical Methods
二、传统中药质量监管制度
…………………………………………………
39
2. Regulatory System on the Quality of TCM
三、科学意义与价值
…………………………………………………………
40
3. Scientific Significance and Value
第二节理化分析技术
…………………………………………………………
42
Ⅱ. Technology of Physical and Chemical Analysis
一、理化分析技术的应用
……………………………………………………
42
1. Application on the Technology of Physical and Chemical Analysis
二、基于“标准”的监管制度
………………………………………………
43
2. Regulatory System Based on “Standards”
三、科学意义与价值
…………………………………………………………
46
3. Scientific Significance and Value
第三节获益
-风险评估
………………………………………………………
47
Ⅲ. Benefit-Risk Assessment
一、中药有效性、安全性与质量评价
………………………………………
48
1. Evaluation on the Efficacy, Safety and Quality of TCM
中药监管科学
二、中药监管科学与获益
-风险综合性能评估
……………………………
50
2. TCM Regulatory Science and the Comprehensive Benefit-Risk Assessment
三、中药注册标准及科学监管体系的建立
…………………………………
51
3. Establishment of TCM Registration Standards and Scientific Regulatory
System
四、科学意义与价值
…………………………………………………………
54
4. Scientific Significance and Value
第四章 中药监管科学的基本概念与科学内涵
Chapter 4 Basic Definitions and Scientific
Connotation of TCM Regulatory
Science059
第一节中药监管:从单纯行政管理到基于科学的监管
…………………
59
Ⅰ. TCM Regulation: From Simple Administrative Management to
Science-Based Regulation
一、中药监管发展现状与监管需求
…………………………………………
59
1. Development Status and Regulatory Demand of TCM Regulation
二、中药监管科学与中药科学监管
…………………………………………
63
2. TCM Regulatory Science and Science-Based TCM Regulation
第二节中药监管科学的科学内涵与特殊性…………………………………
67
Ⅱ. Scientific Connotation and Particularity of TCM Regulatory Science
一、中药监管科学的定义与科学内涵
………………………………………
67
1. Definitions and Scientific Connotation of TCM Regulatory Science
二、中药监管科学的特殊性
…………………………………………………
69
2. Particularity of TCM Regulatory Science
三、中药监管科学的知识体系
………………………………………………
73
3. Knowledge System of TCM Regulatory Science
第三节中药监管科学的研究内容
……………………………………………
77
Ⅲ. Research Contents of TCM Regulatory Science
一、创制中药监管科学新工具
………………………………………………
78
1. Creation of New Tools on TCM Regulatory Science
二、完善中药监管科学新标准
………………………………………………
79
2. Improvement of New Standards on TCM Regulatory Science
三、发展中药监管科学新方法
………………………………………………
80
3. Development of New Methods on TCM Regulatory Science
目 录
第四节中药监管科学与中医药传承创新……………………………………
85
Ⅳ. TCM Regulatory Science and TCM Inheritance and Innovation
一、中药监管科学有助于推动中西医融合创新发展
………………………
85
1. Promotion of the Integration, Innovation and Development of TCM and
Western Medicine
二、中药监管科学有助于加速中药新技术新产品转化上市
………………
86
2. Acceleration of the Marketing of TCM New Technology and New Products
三、中药监管科学有助于实现高水平中药安全监管
………………………
87
3. Achievement of High-Level Regulation on TCM Safety
四、中药监管科学有助于中药产业高质量发展
……………………………
88
4. High-Quality Development of TCM Industry
五、中药监管科学有助于中药全球化监管协调
……………………………
89
5. International Regulatory Harmonization on TCM
第五章 中药监管科学的学科体系
Chapter 5 Discipline System of TCM
Regulatory Science092
第一节中药监管科学学科建设必要性
………………………………………
92
Ⅰ. Necessity on the Establishment of TCM Regulatory Science Discipline
一、高质量中药监管亟需建立标准化和系统化的学科体系
………………
93
1. Establishment of Standardized and Systematic Discipline System for High-
Quality TCM Regulation
二、完善学科体系建设有助于维护公众健康
………………………………
93
2. Promotion of Public Health by Improving Discipline System
三、建立完善专业人才培养体系是中药监管可持续发展的保障
…………
93
3. Establishment of Professional Training System to Guarantee the Sustainable
Development of TCM Regulation
四、中药监管科学研究助推中药传承创新发展和国际化进程
……………
94
4. Promotion of TCM Inheritance, Innovation, Development and
Internationalization by TCM Regulatory Science
第二节中药监管科学学科体系基本内容……………………………………
95
Ⅱ. Basic Contents of TCM Regulatory Science Discipline System
一、中药监管科学学科体系概念与涵盖范围
………………………………
95
1. Concept and Scope of TCM Regulatory Science Discipline System
二、中药监管科学学科体系与中药监管挑战应对
…………………………
97
2. TCM Regulatory Science Discipline System and Response to the Challenges
of TCM Regulation
中药监管科学
第三节中药监管科学人才培养模式
…………………………………………
100
Ⅲ
. Personnel Training Model of TCM Regulatory Science
一、课程教学
…………………………………………………………………
100
1. Teaching Courses
二、交叉科研团队
……………………………………………………………
102
2. Cross Disciplinary Research Team
三、高水平学科平台
…………………………………………………………
103
3. High-Level Discipline Platform
四、高质量科研成果
…………………………………………………………
104
4. High-Quality Scientific Research Achievements
第四节学历教育与证书教育
…………………………………………………
105
Ⅳ. Academic Education and Certificate Education
一、本科生教育
………………………………………………………………
105
1. Undergraduate Education
二、研究生教育
………………………………………………………………
106
2. Postgraduate Education
三、继续教育与培训
…………………………………………………………
106
3. Continuing Education and Training
四、各高等院校中药监管科学教育项目介绍
………………………………
107
4. Introduction of TCM Regulatory Science Education Programs in Higher
Education Institutions
第六章 中药监管科学发展战略、重点任务与组织实施
Chapter 6 Development Strategy, Key Tasks
and Implementation of TCM
Regulatory Science111
第一节中药监管科学发展战略与重点任务…………………………………
111
Ⅰ. Development Strategy and Key Tasks of TCM Regulatory Science
一、中药监管科学面临的重大难题
…………………………………………
111
1. Key Problems on TCM Regulatory Science
二、中药监管科学战略的定位和目标
………………………………………
112
2. Position and Objectives of TCM Regulatory Science Strategy
三、中药监管科学重点任务与路径
…………………………………………
113
3. Key Tasks and Pathways of TCM Regulatory Science
第二节中药监管科学发展支持政策
…………………………………………
124
Ⅱ. Supporting Policies on the Development of TCM Regulatory Science
一、监管科学相关促进政策
…………………………………………………
124
1. Relevant Favorable Policies on Regulatory Science
目 录
二、监管科学发展战略研究
…………………………………………………
127
2. Research on the Development Strategy of Regulatory Science
三、中国药品监管科学行动计划
……………………………………………
127
3. Action Plan on the Drug Regulatory Science in China
四、《全面强化药品监管科学体系建设实施方案》
…………………………
128
4. The Implementation Plan on the Comprehensive Strengthening of Drug
Regulatory Science System
第三节中药监管组织架构与各方责任
………………………………………
129
Ⅲ. Organizational Structures and Responsibilities of TCM Regulation
一、国家药监局机关相关司和直属单位
……………………………………
130
1. Relevant Departments and Affiliate Institutions of NMPA
二、中药监管科学基地与重点实验室
………………………………………
131
2. The Research Bases and Key Laboratories of TCM Regulatory Science
三、其他中药监管科学研究机构及人才培养
………………………………
132
3. Other TCM Regulatory Science Institutes and Personnel Training
第四节中药监管科学重点项目实施
…………………………………………
134
Ⅳ. Implementation of Key Programs on TCM Regulatory Science
一、中国药品监管科学行动计划第一批中药重点项目(2019—2021年)…
134
1. The First Batch of Key TCM Programs in the Action Plan on the Drug
Regulatory Science in China (2019-2021)
二、中国药品监管科学行动计划第二批中药重点项目(2021—2023年)…
135
2. The Second Batch of Key TCM Programs in the Action Plan on the Drug
Regulatory Science in China (2021-2023)
三、药品监管科学体系建设中药重点项目(2024年—至今)………………
136
3. The Key TCM Programs in the Discipline System of Drug Regulatory Science
(2024-now)
第五节中药监管决策咨询与中药监管科学推进措施
……………………
138
Ⅴ. Consultation of the Decision Making Process in TCM Regulation and
Promotion of TCM Regulatory Science
一、中药管理战略决策专家咨询委员会
……………………………………
138
1. The Expert Consultation Committee on the Strategic Decisions for TCM
Regulation
二、中药科学监管重点领域专家工作组
……………………………………
138
2. The Expert Panels on Key Aspects for the Science-Based TCM Regulation
三、中药监管科学研究者联盟机制
…………………………………………
139
3. The Mechanism on the Coalition of TCM Regulatory Science Researchers
Tools
中药监管科学
中篇工具篇
Part Two
第七章 中药监管科学新工具开发方法论
Chapter 7 Methodology on the Development
of New Tools for TCM Regulatory
Science142
第一节监管科学视角下的中西医药认知比较………………………………
142
Ⅰ. Comparison of Cognition between TCM and Western Medicine from the
Vision of Regulatory Science
一、中西药在物质内涵特质性方面“禀赋”迥异
…………………………
143
1. Different Characteristics on the Connotation of Material Resources between
TCM and Western Medicine
二、中西药在研发路径方面存在“志同道不同”……………………………
143
2.“Same Aspirations, Different Paths”, Different Research Pathways between
TCM and Western Medicine
三、中西医在诊疗理念与疗效认知方面“各有所好”………………………
143
3. Different Preferences in the Field of Diagnos and Treatment Concepts and
Efficacy Cognition between TCM and Western Medicine
四、中药监管科学新工具新标准新方法开发的一般原则
…………………
145
4. General Principles on the Development of New Tools, New Standards and
New Methods of TCM Regulatory Science
第二节中药监管科学助推中药新药研发新策略
…………………………
147
Ⅱ. New Strategies on TCM Research and Development Promoted by TCM
Regulatory Science
一、中药新药研发导向:解决尚未满足的临床需求
………………………
147
1. Orientation of New TCM R&D: Satisfy the Unmet Clinical Needs
二、中药新药研发的上佳路径:双向转化医学研究
………………………
147
2. The Best Pathway of New TCM R&D: the Two-Way Translational Medicine
Research
三、中西医融合药物研发新范式:系统辨靶创药
…………………………
148
3. New R&D Paradigm for Integrated TCM and Western Medicine: Target-
Combined Holistic Research
四、中药新药研发的“富矿”:毒剧药、鲜药和大剂量用药
………………
149
4.“High-Grade Ore” of New TCM R&D: the Highly Toxic Medicine,
the Fresh Medicine and Large-Dose Medicine
目 录
五、创新中药发现的新上策:跨器官通讯与间接调控作用
………………
149
5. New Strategies on the Discovery of New TCM: the Cross-Organ
Communication and Indirect Adjustment
六、中药新药研发的“神助手”:人工智能
+大数据
………………………
149
6. The Best Assistant on New TCM Research and Development:
AI and Big Data
第三节符合中药特点的中药监管科学方法学创新
………………………
150
Ⅲ. Innovation on the Methodology of TCM Regulatory Science with the
Characteristics of TCM
一、中药质量监管方法学创新:中药大质量观及新方法
…………………
150
1. Innovation on the Methodology of TCM Quality Regulation: the Great
Quality Concept and New Methods
二、中药安全性监管方法学创新:中药新安全观及新方法
………………
154
2. Innovation on the Methodology of TCM Safety Regulation: the New Safety
Concept and New Methods
三、中药有效性评价方法学创新:整合证据链法
…………………………
158
3. Innovation on the Methodology of TCM Efficacy Assessment: the Integrated
Evidence Chain
第八章 中药监管科学新工具的评价与资格认定
Chapter 8 Assessment and Qualification of
New TCM Regulatory Science
Tools163
第一节美国
FDA药物研发工具资格认定及程序
…………………………
163
Ⅰ. Qualification and Procedures of Drug Research and Development Tools by
U.S. FDA
一、药物研发工具的产生背景
………………………………………………
164
1. Background of Drug Research and Development Tools
二、药物研发工具资格认定
…………………………………………………
165
2. Qualification of Drug Research and Development Tools
三、FDA药物研发工具资格认定类型
………………………………………
165
3. Patterns on the Qualification of Drug Research and Development Tools by
U.S. FDA
四、药物研发工具资格认定程序
……………………………………………
168
4. Procedures on the Qualification of Drug Research and Development Tools
中药监管科学
第二节中药监管测量和评价新工具的资格认定策略
……………………
169
Ⅱ. Qualification Strategies on the Measurement and Assessment of
New TCM Regulatory Tools
一、中药监管新工具的发展与需求
…………………………………………
170
1. Development and Demand of New TCM Regulatory Tools
二、中药监管测量和评价新工具资格认定策略
……………………………
171
2. Qualification Strategies on the Measurement and Assessment of New TCM
Regulatory Tools
三、认证管理与实施
…………………………………………………………
172
3. Management and Implementation of Qualification
第三节中药临床评价核心指标集研制遴选程序
…………………………
173
Ⅲ. Research and Selection Procedure on the Core Indicator Sets of
TCM Clinical Evaluation
一、核心指标集概念和作用
…………………………………………………
174
1. Definitions and Functions of Core Indicator Sets
二、中医药核心指标集研究现状
……………………………………………
174
2. Current Status on the Research of Core Indicator Sets of TCM
三、中医药核心指标集研制基本原则
………………………………………
175
3. Basic Principles on the Research of Core Indicator Sets of TCM
四、中医药核心指标集研制遴选程序
………………………………………
175
4. Research and Selection Procedures of Core Indicator Sets of TCM
第四节我国药品技术指导原则发布程序……………………………………
180
Ⅳ. Release Procedures of Technical Guidelines of Drugs
一、药品技术指导原则发展历程
……………………………………………
180
1. Development of Technical Guidelines of Drugs
二、药品技术指导原则监管成效
……………………………………………
181
2. Regulatory Achievements on Technical Guidelines of Drugs
三、药品技术指导原则发布程序
……………………………………………
182
3. Procedures on the Release of Technical Guidelines of Drugs
第五节国家药典委员会药品标准编制程序…………………………………
183
Ⅴ. Procedures on the Formulation of Drug Standards by China Pharmacopoeia
Commission
一、药品标准的编制要求
……………………………………………………
183
1. Requirements on the Development of Drug Standards
二、药品标准的编制程序
……………………………………………………
184
2. Procedures on the Development of Drug Standards
目 录
第九章 中药临床价值发现与有效性安全性评价
Chapter 9 Discovery of Clinical Value and
Evaluation on the Efficacy and
Safety of TCM188
第一节中药临床评价的特殊性与监管需求…………………………………
188
Ⅰ. Characteristics and Regulatory Demands on the Clinical Evaluation of TCM
一、中药临床价值的特点
……………………………………………………
188
1. Characteristics of TCM Clinical Value
二、中药有效性评价的特殊性
………………………………………………
192
2. Characteristics on the Efficacy Evaluation of TCM
三、现行中药临床评价方法问题与监管需求
………………………………
193
3. Problems and Regulatory Demands on the Current Methods of TCM Clinical
Evaluation
第二节中药临床有效性评价的原则及基本方法
…………………………
197
Ⅱ. Principles and Basic Evaluation Methods on TCM Clinical Efficacy
一、中药临床评价研究现状
…………………………………………………
197
1. Current Status on the Research of TCM Clinical Evaluation
二、中药临床有效性评价的考虑
……………………………………………
199
2. Consideration on the TCM Clinical Efficacy Evaluation
第三节真实世界评价方法
……………………………………………………
208
Ⅲ. Methods of Real World Assessment
一、真实世界研究相关概念及其价值
………………………………………
208
1. Relevant Definitions and Values of Real World Research
二、观察性真实世界研究
……………………………………………………
211
2. Observational Real World Research
三、试验性真实世界研究
……………………………………………………
216
3. Experimental Real World Research
第四节适应性设计与中药有效性评价
………………………………………
222